Medigene (0QGJ) Stock Statistics & Valuation Metrics

Medigene has a market cap or net worth of $902.19K. The enterprise value is ―.

Medigene has 14,887,594 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medigene’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Medigene is -4.37. Medigene’s PEG ratio is -0.84.

In the last 12 months, Medigene had revenue of 6.03M and earned -16.18M in profits. Earnings per share was -0.66.

In the last 12 months, operating cash flow was -14.17M and capital expenditures -621.00K, giving a free cash flow of -14.79M billion.

Medigene pays an annual dividend of ―, resulting in a dividend yield of ―

Medigene upcoming earnings date is May 14, 2025, TBA Not Confirmed.

Medigene as a current ratio of 2.53, with Debt / Equity ratio of 12.95%

In the past 12 months, Medigene has paid -415.00K in taxes.

Medigene EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Medigene has $14.02M in cash and marketable securities with €2.54M in debt, giving a net cash position of -$11.48M billion.

Gross margin is 78.39%, with operating margin of -267.63%, and net profit margin of -268.10%.

The average price target for Medigene is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold